UMC Hospitals Achieves Milestone with First IVUS-Guided Coronary Intervention, Advancing Cardiac Care

UMC Hospitals Achieves Milestone with First IVUS-Guided Coronary Intervention, Advancing Cardiac Care​

Unihealth Hospitals Limited (NSE: UNIHEALTH) announced that its UMC Hospitals in Navi Mumbai has successfully completed its first Intravascular Ultrasound (IVUS)-Guided Coronary Intervention, marking a significant step forward in enhancing the hospital's cardiac care capabilities. The procedure was executed by Dr. Shrikant Naigude, utilizing advanced intravascular imaging technology to improve precision in managing coronary artery disease.

The successful adoption of this technique reflects UMC Hospitals' commitment to integrating globally accepted best practices and advanced medical technologies into its treatment protocols.

Understanding IVUS-Guided Intervention​

Intravascular Ultrasound (IVUS) is a sophisticated imaging modality that involves using a miniature ultrasound probe mounted on the tip of a coronary catheter. This technology allows physicians to visualize the artery from within, offering detailed cross-sectional views of the vessel wall and plaque composition.

Unlike conventional angiography, which provides a two dimensional silhouette of the blood vessels when using contrast dye, IVUS enables interventional cardiologists to accurately assess blockage severity, select the optimal stent size, ensure precise deployment, and verify complete stent expansion against the vessel wall.

The procedure offers multiple advantages for patients, including:

• Enhanced procedural accuracy through detailed visualization of coronary anatomy.
• Improved stent placement, reducing the risk of malposition or under-expansion.
• Better long term clinical outcomes, potentially leading to lower rates of restenosis and reduced complications such as stent thrombosis.

The integration of IVUS into interventional cardiology is increasingly recognized globally as a valuable tool for improving both safety and effectiveness in coronary angioplasty procedures.

Commitment to Advanced Cardiac Care​

The successful execution of this procedure underscores UMC Hospitals' ongoing investment in advanced medical technologies and evidence based treatment protocols. The hospital’s cardiac sciences program is supported by experienced clinicians, critical care services, a modern catheterization laboratory infrastructure, and multidisciplinary teams dedicated to comprehensive cardiovascular care.

Dr. Shrikant Naigude stated that the introduction of IVUS-guided coronary intervention represents an important step toward delivering precision driven cardiac care. He added that providing detailed insights into the coronary arteries allows for better informed decisions during procedures, leading to enhanced patient safety and improved outcomes for those in Navi Mumbai and surrounding communities.

UMC Hospitals provides a wide spectrum of specialized services across cardiology, cardiac sciences, internal medicine, critical care, general surgery, orthopaedics, spine, nephrology, gastroenterology, pulmonology, neurology, oncology, emergency medicine, diagnostics, and preventive healthcare.

Corporate Vision and Growth Strategy​

The milestone at UMC Hospitals is part of Unihealth Hospitals Limited's larger vision to continuously elevate healthcare standards through innovation and patient focused care. The Company views this achievement as signifying an unwavering commitment to clinical excellence.

Dr. Akshay Parmar, Founder and Managing Director of Unihealth Hospitals Limited, commented on the significance of the event. He stated that the introduction of IVUS at UMC Hospitals reflects the company's dedication to bringing globally accepted, technology enabled healthcare solutions to communities. This achievement aligns with the corporate strategy to expand the healthcare footprint, enhance specialist care capabilities, and build centers of excellence across their network.

Unihealth Hospitals Limited was established in Mumbai in 2010 as an integrated healthcare platform focused on delivering affordable, accessible, and high quality services across India and East Africa. The company operates through multiple verticals, including hospital operations, healthcare consultancy, pharmaceutical and consumables exports, and medical value travel.

Financial Performance for FY26​

For the fiscal year 2026, Unihealth Hospitals Limited reported strong consolidated financial performance:

UNIHEALTH Stock Price Movement​

Shares of Unihealth Hospitals Limited are surging to ₹547.75 as of 12:27 PM, gaining 4.98% in live trading and climbing robustly from the previous close. This significant upward momentum sees Unihealth achieve its 52-week high, with 33,500 shares currently traded as investor sentiment strengthens.